David Hollander Aerie Pharmaceuticals Inc (AERI) insider trading activity

AERI Quotes by TradingView

David Hollander is Chief R&D Officer of AERIE PHARMACEUTICALS INC. Currently has a direct ownership of 30,749 shares of AERI, which is worth approximately $0. The most recent transaction as insider was on Feb 04, 2022, when has been sold 927 shares (Common Stock) at a price of $7.05 per share, resulting in proceeds of $6,535. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 30.7K
0% 3M change
0% 12M change
Total Value Held $0

David Hollander Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 04 2022
SELL
Payment of exercise price or tax liability
$6,535 $7.05 p/Share
927 Reduced 2.93%
30,749 Common Stock
Nov 11 2021
SELL
Payment of exercise price or tax liability
$26,074 $12.06 p/Share
2,162 Reduced 6.39%
31,676 Common Stock
Feb 04 2021
BUY
Grant, award, or other acquisition
-
11,000 Added 24.53%
33,838 Common Stock
Nov 11 2020
SELL
Payment of exercise price or tax liability
$28,214 $13.05 p/Share
2,162 Reduced 8.65%
22,838 Common Stock

Also insider at

KPRX
KIORA PHARMACEUTICALS INC Healthcare
Director
RVNC
Revance Therapeutics, Inc. Healthcare
CMO & Global Therapeutics Lead
DH

David Hollander

Chief R&D Officer
Durham, NC

Track Institutional and Insider Activities on AERI

Follow AERIE PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AERI shares.

Notify only if

Insider Trading

Get notified when an Aerie Pharmaceuticals Inc insider buys or sells AERI shares.

Notify only if

News

Receive news related to AERIE PHARMACEUTICALS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AERI